A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.

Pfizer

Status and phase: Completed; Phase 3

Conditions: Candidiasis

Treatments: Drug: Diflucan IV, oral; Drug: Conventional amphotericin B; Drug: VFEND® I.V., Oral

Study type: Interventional

Funder types: Industry

Identifiers

NCT00163111

608

A1500608

Details and patient eligibility

About

This is a study to investigate the safety and efficacy of voriconazole for the treatment of candidemia in critically ill non-neutropenic patients

Enrollment: 412 patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with candidemia

Exclusion criteria

• Neutropenia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)